Top 5 Performers: NASDAQ Composite Index touched 13,620.71 High till 2PM
The National Association of Securities Dealers Automated Quotations (NASDAQ) Composite Index opened at 13,523.17 on 16th March 2021. Till 2 PM the highest it touched was 13,620.71 and lowest 13,478.93
Top 5 Performers Till 2 PM:
Savara Inc. (Change% 45.20 priced at $2.5)
Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.
FinTech Acquisition Corp. V Cl A (Change% 34.85 priced at $14.5)
FinTech Acquisition Corp. V is a special purpose acquisition company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, with a focus on financial technology business.
Lizhi Inc. ADR (Change% 33.20 priced at $14)
Lizhi, Inc. owns and operates an interactive audio entertainment platform and an online audio platform in China. The company’s app Lizhi allows users to create, store and share their own podcasts on mobile devices with the help of intuitive recording and reach their audience through various discovery tools. Lizhi was founded by Jinnan Lai and Ning Ding in November 2010 and is headquartered in Guangzhou, China.
New Fortress Energy LLC Cl A (Change% 27.93 priced at $54.3)
New Fortress Energy Inc. is a holding company, which operates as an integrated gas-to-power energy infrastructure company. It funds, builds, and operates natural gas infrastructure and logistics to deliver fully integrated turnkey energy solutions that enable economic growth, enhance environmental stewardship, and transform local industries and communities. The company was founded by Wesley R. Edens on February 25, 2014 and is headquartered in New York, NY.
Cyclo Therapeutics Inc. (Change% 26.72 priced at $12.8)
Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product candidates include Trappsol Cyclo, which treats Neimann-Pick Type C disease. The firm focuses on the development and commercialization of innovative cyclodextrin-based products for the treatment of people with serious and life threatening rare diseases and medical conditions. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.
